•  
  •  
  •  
  •  

2022-08-19 03:41:25

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Syrma SGS Technology IPO subscribed 32.61 times on the final day
  • NHPC signs MoU with Investment Board Nepal, Govt. of Nepal
  • Knowledge Marine & Engineering Works Ltd acquires new vessel
  • MIL's PAT Q1 FY 23 up 96 pc, plans multifold expansion in Africa
  • Seacoast Shipping Services Ltd board approves 1:1 rights issue

Keywords Selected:  USFDA

Stock Report

  • Strides receives USFDA approval for Naproxen Sodium OTC Softgel Capsules
  • Lupin receives approval from U.S. FDA for Rufinamide Tablets USP
  • NATCO announces tentative approval to its ANDA for Trabectedin
  • Unichem Laboratories receives ANDA Approval for Quetiapine Extended-Release Tablets
  • Eugia Pharma receives USFDA Approval for Vasopressin Injection USP
  • Sun Pharmaceutical Industries Ltd Update on US FDA Inspection at Mohali Facility
  • Sun Pharmaceutical Industries Ltd receives OAI from USFDA for Halol facility
  • Lupin receives approval from U.S. FDA for Meclizine Hydrochloride Tablets USP
  • Zydus receives final approval from the USFDA for Prochlorperazine Maleate Tablets
  • Strides announces successful completion of US FDA inspection at its Singapore facility
  • Aleor Dermaceuticals Ltd receives USFDA Final Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%
  • Zydus Lifesciences Ltd gets 4 observations from USFDA for Moraiya facility
  • Aurobindo Pharma Ltd completes US FDA Inspection at its Unit VII
  • Zydus receives final approval from the USFDA for Ivermectin Cream
  • Strides receives USFDA approval for Cyclosporine Softgel Capsules
  • USFDA issues 3 observations for Aurobindo Pharma Ltd's Unit XI
  • Jubilant Pharmova gets 6 observations from USFDA for its Solid Dosage Manufacturing Facility at Roorkee, India
  • Casper Pharma completed USFDA pre-approval inspection
  • Shilpa Medicare's Unit III, Advanced Analytical Characterization Laboratory clears US FDA Remote Record Review
  • Aleor Dermaceuticals Limited receives USFDA Final Approval for Diclofenac Sodium Topical Gel, 3%
  • Glenmark Pharmaceuticals receives ANDA approval for generic version of Taytulla®
  • Dr. Reddy's Laboratories launches Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market
  • Zydus receives final approval from the USFDA for Bisoprolol Fumarate Tablets
  • Lupin receives approval from U.S. FDA for Azilsartan Medoxomil Tablets

Latest Post

  • Syrma SGS Technology IPO subscribed 32.61 times on the final day
  • NHPC signs MoU with Investment Board Nepal, Govt. of Nepal
  • Knowledge Marine & Engineering Works Ltd acquires new vessel
  • MIL's PAT Q1 FY 23 up 96 pc, plans multifold expansion in Africa
  • Seacoast Shipping Services Ltd board approves 1:1 rights issue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2021